olivlawolivlaw

olivLaw · US equity research

CME Group Inc. CME

Security & Commodity Brokers, Dealers, Exchanges & Services · SIC 6200 · Vertical: Security & Commodity Brokers, Dealers, Exchanges & Services (SIC 6200)

307.24USD−0.33% · 1 dayClose 05 Nov 2026

CME Group is the world's leading derivatives marketplace, headquartered in Chicago, offering futures, options, cash and OTC products and operating a central counterparty clearing house. Total revenues reached 1737.3 million USD in the third quarter of 2026, up 13% year on year. Revenue is dominated by clearing and transaction fees, which depend on contract volume.

At the close of 05 Nov 2026, CME Group Inc. (CME) stock was 307.24 USD (−0.33% on the day), with market capitalisation 20.5 bn USD, P/E 25.1 on diluted EPS of 12.23 USD over the last 12 months, dividend yield 3.68%, beta -0.15, 52-week range 218.58–326.46 USD. Latest reported quarter (Q3 2026): revenue of 1.7 bn USD (+13.0% YoY), net income of 1.0 bn USD (+14.2% YoY), diluted EPS 2.89 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
20.5 bn USD
shares as of 17 Feb 2010
P/E (TTM)
25.1
Diluted EPS TTM 12.23 · TTM to 30 Sept 2026
E/P (TTM)
3.98%
TTM to 30 Sept 2026
Dividend yield
3.68%
DPS 12m 11.30
Beta (2y)
-0.15
Volatility (1y) 25%
52-week range
218.58326.46

Price history

Loading chart…

Technical reading

RSI (14)
66.0
strong (55–70)
Bollinger (20, 2)
276.49 – 315.71
in the upper half of the band · %B 0.78 · band width 13.2%
SMA 50 / 200
282.60 / 280.76
uptrend (price > SMA50 > SMA200)
MACD (12, 26, 9)
7.87 / 7.39
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month+13.7%−5.9%+19.7 pp—
3 months+16.2%−4.6%+20.9 pp—
6 months+7.1%+0.2%+6.9 pp—
Year to date+12.5%+7.4%+5.1 pp—
1 year+14.6%+8.2%+6.4 pp+10.6%
3 years+44.2%+68.4%−24.2 pp+35.4%
5 years+38.6%+56.5%−18.0 pp—
Max drawdown (1y)
−33.0%
02 Mar 2026 → 29 Jun 2026
Max drawdown (5y)
−33.1%
21 Mar 2022 → 27 Dec 2022
Compound annual growth (5y)
+6.7%
S&P 500 +9.4%

Price returns, dividends excluded.

Quarterly results

Latest quarter: Q3 2026 · 30 Sept 2026

Revenue
1.7 bn USD
+13.0% YoY
Net income
1.0 bn USD
+14.2% YoY
Diluted EPS
2.89
+16.1% YoY
net / operating
59.7% / 65.7%

Quarterly margins

Quarterly statements · USD

Fiscal yearQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Revenue1.5 bn1.6 bn1.7 bn1.5 bn1.6 bn1.9 bn1.7 bn1.7 bn
Operating income947.1 m1.1 bn1.1 bn972.6 m1.0 bn1.3 bn1.1 bn1.1 bn
Interest expense40.7 m41.7 m44.0 m44.0 m43.7 m43.6 m43.6 m43.5 m
Pre-tax income1.1 bn1.2 bn1.3 bn1.2 bn1.6 bn1.5 bn1.3 bn1.4 bn
Income tax222.0 m288.6 m305.2 m269.0 m395.5 m356.6 m285.9 m317.9 m
Net income874.6 m956.2 m1.0 bn908.0 m1.2 bn1.2 bn1.0 bn1.0 bn
Diluted EPS2.43 ≈2.622.812.493.28 ≈3.182.882.89
Operating cash flow1.0 bn1.1 bn1.1 bn ≈968.1 m ≈1.1 bn1.3 bn947.1 m ≈1.1 bn ≈
Capex26.2 m14.2 m18.4 m ≈18.4 m ≈32.5 m21.8 m23.6 m ≈15.8 m ≈
Dividends paid418.8 m2.6 bn455.3 m ≈455.3 m ≈455.0 m2.7 bn468.1 m ≈464.8 m ≈

≈ derived quarter (cumulative difference / share-days average)

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 50 percentile of its own 44-quarter history (min 12.2, median 25.2, max 39.8; quarters with earnings only).

Fiscal years

Fiscal year20182019202020212022202320242025
Revenue4.3 bn4.9 bn4.9 bn4.7 bn5.0 bn5.6 bn6.1 bn6.5 bn
Revenue YoY+18.2%+13.0%+0.3%−4.0%+7.0%+11.1%+9.9%+6.4%
Net income2.0 bn2.1 bn2.1 bn2.6 bn2.7 bn3.2 bn3.5 bn4.1 bn
Net income YoY−51.7%+7.9%−0.5%+25.2%+2.0%+19.9%+9.3%+15.5%
Diluted EPS5.715.915.877.297.408.869.6711.16
Diluted EPS YoY−52.2%+3.5%−0.7%+24.2%+1.5%+19.7%+9.1%+15.4%
net %45.5%43.5%43.1%56.2%53.6%57.8%57.5%62.5%
Free cash flow2.3 bn2.4 bn2.5 bn2.3 bn3.0 bn3.4 bn3.6 bn4.2 bn

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
4.4 bn USD
Financial debt
0 USD
Net debt
-4.4 bn USD
Equity
28.7 bn USD
Total assets
198.4 bn USD
Debt / equity
0.00x
Current ratio
1.03x
ROE
14.8%
ROA
2.4%
FCF margin
64.3%

Financial statements (source on every figure)

Revenue and net income (USD)

Margins

Income statement · USD

Revenue
2023
5.6 bn
2024
6.1 bn
2025
6.5 bn

SEC (XBRL)· 26 Feb 2026verified

Operating income
2023
3.4 bn
2024
3.9 bn
2025
4.2 bn

SEC (XBRL)· 26 Feb 2026verified

Depreciation & amortisation
2023
126.0 m
2024
115.1 m
2025
107.5 m

SEC (XBRL)· 26 Feb 2026verified

EBITDA
2023
3.6 bn ≈
2024
4.0 bn ≈
2025
4.3 bn ≈

SEC (XBRL)· 26 Feb 2026derived

Interest expense
2023
159.4 m
2024
160.9 m
2025
173.4 m

SEC (XBRL)· 26 Feb 2026verified

Pre-tax income
2023
4.2 bn
2024
4.5 bn
2025
5.3 bn

SEC (XBRL)· 26 Feb 2026verified

Income tax
2023
927.4 m
2024
1.0 bn
2025
1.3 bn

SEC (XBRL)· 26 Feb 2026verified

Net income
2023
3.2 bn
2024
3.5 bn
2025
4.1 bn

SEC (XBRL)· 26 Feb 2026verified

Diluted EPS
2023
8.86
2024
9.67
2025
11.16

SEC (XBRL)· 26 Feb 2026verified

Weighted average diluted shares
2023
359.5 m
2024
359.9 m
2025
360.3 m

SEC (XBRL)· 26 Feb 2026verified

Dividend per share
2023
9.65
2024
10.40
2025
5.00

SEC (XBRL)· 26 Feb 2026verified

Balance sheet · USD

Cash
2023
2.9 bn
2024
2.9 bn
2025
4.4 bn

SEC (XBRL)· 26 Feb 2026verified

Receivables
2023
535.6 m
2024
573.1 m
2025
639.2 m

SEC (XBRL)· 26 Feb 2026verified

Current assets
2023
94.9 bn
2024
103.0 bn
2025
165.4 bn

SEC (XBRL)· 26 Feb 2026verified

Property, plant & equipment, net
2023
409.5 m
2024
386.2 m
2025
362.7 m

SEC (XBRL)· 26 Feb 2026verified

Goodwill
2023
10.5 bn
2024
10.5 bn
2025
10.5 bn

SEC (XBRL)· 26 Feb 2026verified

Intangibles (excl. goodwill)
2023
3.1 bn
2024
2.8 bn
2025
2.2 bn

SEC (XBRL)· 24 Jul 2026verified

Total assets
2023
129.7 bn
2024
137.4 bn
2025
198.4 bn

SEC (XBRL)· 26 Feb 2026verified

Accounts payable
2023
90.6 m
2024
79.9 m
2025
71.8 m

SEC (XBRL)· 26 Feb 2026verified

Short-term debt
2023
0
2024
749.8 m
2025
0

SEC (XBRL)· 26 Feb 2026verified

Current liabilities
2023
93.4 bn
2024
102.3 bn
2025
160.3 bn

SEC (XBRL)· 26 Feb 2026verified

Total liabilities
2023
103.0 bn
2024
111.0 bn
2025
169.7 bn

SEC (XBRL)· 26 Feb 2026verified

Equity
2023
26.7 bn †
2024
26.5 bn †
2025
28.7 bn †

SEC (XBRL)· 26 Feb 2026verified

Cash flow · USD

Operating cash flow
2023
3.5 bn
2024
3.7 bn
2025
4.3 bn

SEC (XBRL)· 26 Feb 2026verified

Capex
2023
76.4 m
2024
94.0 m
2025
83.5 m

SEC (XBRL)· 26 Feb 2026verified

Free cash flow
2023
3.4 bn ≈
2024
3.6 bn ≈
2025
4.2 bn ≈

SEC (XBRL)· 26 Feb 2026derived

Investing cash flow
2023
20.9 m
2024
-82.6 m
2025
1.5 bn

SEC (XBRL)· 26 Feb 2026verified

Financing cash flow
2023
-48.3 bn
2024
5.1 bn
2025
56.5 bn

SEC (XBRL)· 26 Feb 2026verified

Dividends paid
2023
3.2 bn
2024
3.6 bn
2025
3.9 bn

SEC (XBRL)· 26 Feb 2026verified

Computed indicators

Growth

Revenue growth (YoY)
6.4%
computed by olivLawFY 2025
Revenue CAGR 3Y
9.1%
computed by olivLawFY 2022 → FY 2025
Revenue CAGR 5Y
6.0%
computed by olivLawFY 2020 → FY 2025
EBIT growth (YoY)
7.6%
computed by olivLawFY 2025
Net income growth (YoY)
15.5%
computed by olivLawFY 2025
Net income CAGR 3Y
14.8%
computed by olivLawFY 2022 → FY 2025
Net income CAGR 5Y
14.1%
computed by olivLawFY 2020 → FY 2025
EPS growth (YoY)
15.4%
computed by olivLawFY 2025
EPS CAGR 3Y
14.7%
computed by olivLawFY 2022 → FY 2025
EPS CAGR 5Y
13.7%
computed by olivLawFY 2020 → FY 2025
FCF growth (YoY)
16.6%
computed by olivLawFY 2025

Profitability

Gross margin
unavailable
input data missing
EBITDA margin
67.2%
computed by olivLawTTM to 30 Sept 2026
EBIT margin
65.7%
computed by olivLawTTM to 30 Sept 2026
Net margin
63.3%
computed by olivLawTTM to 30 Sept 2026
FCF margin
62.1%
computed by olivLawTTM to 30 Sept 2026

Returns

ROE
16.1%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
ROA
2.3%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
ROIC
unavailable
input data missing
ROCE
12.7%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Payout ratio (EPS)
92.4%
computed by olivLawTTM to 30 Sept 2026
Payout ratio (FCF)
94.3%
computed by olivLawTTM to 30 Sept 2026

Balance sheet

Net debt
unavailable
input data missing
Net debt / EBITDA
unavailable
input data missing
Debt / equity
unavailable
input data missing
Interest coverage
26.2x
computed by olivLawTTM to 30 Sept 2026

Liquidity

Current ratio
1.0x
computed by olivLawbalance sheet at 30 Sept 2026
Quick ratio
unavailable
input data missing
Cash ratio
0.0x
computed by olivLawbalance sheet at 30 Sept 2026

Cash

Operating cash flow
4.4 bn USD
computed by olivLawTTM to 30 Sept 2026
Capital expenditure
93.7 m USD
computed by olivLawTTM to 30 Sept 2026
Free cash flow
4.3 bn USD
computed by olivLawTTM to 30 Sept 2026
FCF conversion
98.1%
computed by olivLawTTM to 30 Sept 2026
Cash conversion
94.5%
computed by olivLawTTM to 30 Sept 2026

Efficiency

Days sales outstanding
37 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Days inventory outstanding
unavailable
input data missing
Days payables outstanding
unavailable
input data missing
Cash conversion cycle
unavailable
input data missing

Market and valuation

Market capitalisation
20.5 bn USD
computed by olivLawbalance sheet at 30 Sept 2026
Enterprise value
unavailable
input data missing
Market cap / net income TTM
4.6x
computed by olivLawTTM to 30 Sept 2026
P/E (TTM)
25.1x
computed by olivLawTTM to 30 Sept 2026
Earnings yield
4.0%
computed by olivLawTTM to 30 Sept 2026
P/B
0.8x
computed by olivLawbalance sheet at 30 Sept 2026
P/S
2.9x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
EV/EBITDA
unavailable
input data missing
EV/EBIT
unavailable
input data missing
EV/Sales
unavailable
input data missing
P/FCF
4.7x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
FCF yield
21.2%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Dividend yield
3.7%
computed by olivLawTTM to 30 Sept 2026
Shareholder yield (distributions)
20.0%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Neutral profile

Score: 78 / 100

A scoring methodology on indicators and valuation, not investment advice.

Closing price

307.24 USD

05 Nov 2026Source: olivLaw, closing series

Market cap: 20.5 bn USD

Key indicators

Market capitalisation
20.5 bn USD
computed by olivLawbalance sheet at 30 Sept 2026
P/E (TTM)
25.1x
computed by olivLawTTM to 30 Sept 2026
P/B
0.8x
computed by olivLawbalance sheet at 30 Sept 2026
EV/EBITDA
unavailable
input data missing
ROE
16.1%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Net margin
63.3%
computed by olivLawTTM to 30 Sept 2026
Revenue growth (YoY)
6.4%
computed by olivLawFY 2025
Dividend yield
3.7%
computed by olivLawTTM to 30 Sept 2026

Coverage and freshness

29/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 30 Sept 2026
Latest balance sheet date: 30 Sept 2026
Share count (cover of the latest filing), as of: 17 Feb 2010
Source: SEC (XBRL)published 23 Oct 2026
verified 2567derived 168

Score by group

  • Balance sheet67
  • Returns75
  • Quality99
  • Growth87
  • Valuation63

Estimated value range

Low
135.79
USD per share
Mid
182.93
USD per share
High
200.14
USD per share
Price: 307.24 USD
The price is above the range
Potential to the central value: -40.5% (value / price − 1)
Margin of safety: -68.0% (1 − price / value)
Agreement between methods: low · 2 methods used · 2 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 65.71 – 311.92 USD.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)unavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
  • Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
  • Peers: P/E205.88 – 311.92 (Mid 290.49)
    9 companies used · median multiple 23.7x · quartiles 16.8x – 25.5x
    BGC, CBOE, GSIW, ICE, LPLA, MRX, NDAQ, SNEX, TW
  • Dividend discount (DDM)65.71 – 88.36 (Mid 75.37)
Multiple comparisons use the SIC vertical: Security & Commodity Brokers, Dealers, Exchanges & Services (SIC 6200)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Neutral profile · Score 78/100

FactorValueScoreWeight used
ROIC · Qualityunavailableunavailable—
Net margin · Quality63.3%100 (vs peers)9%
FCF conversion · Quality98.1%97 (on a fixed band)9%
Revenue CAGR 3Y · Growth9.1%76 (on a fixed band)12%
EPS CAGR 3Y · Growth14.7%98 (on a fixed band)12%
Net debt / EBITDA · Balance sheetunavailableunavailable—
Interest coverage · Balance sheet26.2x100 (on a fixed band)9%
Current ratio · Balance sheet1.0x18 (on a fixed band)6%
P/E (TTM) · Valuation25.1x33 (vs peers)15%
EV/EBITDA · Valuationunavailableunavailable—
FCF yield · Valuation21.2%100 (on a fixed band)12%
Shareholder yield (distributions) · Returns20.0%100 (on a fixed band)9%
Payout ratio (FCF) · Returns94.3%37 (on a fixed band)6%

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet67/100 · 2/3 factors with a value
  • Growth87/100 · 2/2 factors with a value
  • Quality99/100 · 2/3 factors with a value
  • Returns75/100 · 2/2 factors with a value
  • Valuation63/100 · 2/3 factors with a value

Memo

CME GROUP INC. (CME). Latest full fiscal year: 2025; data up to 2026-09-30.

Figures computed from the financial statements: revenue 6.5 bn USD in 2025; YoY growth 6.4%; net margin 63.3%; ROE 16.1%.

The estimated value range is 135.79–200.14 USD per share (median of 2 methods, agreement: low); assumptions are illustrative. Against the central value of 182.93 USD, the price of 307.24 USD leaves a potential of -40.5% (value / price − 1) and a margin of safety of -68.0% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

olivLaw score 78/100, methodological classification: neutral profile (score, margin of safety and method agreement together; not a judgement of the right price). Not investment advice.

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • Net margin: 63.3%
  • FCF conversion: 98.1%
  • Revenue CAGR 3Y: 9.1%
  • EPS CAGR 3Y: 14.7%
  • Interest coverage: 26.2x
  • FCF yield: 21.2%
  • Shareholder yield (distributions): 20.0%

What contradicts it

  • Current ratio: 1.0x
  • The price is above the estimated value range
  • The valuation methods diverge

Not assessed (insufficient data or a ratio without meaning): ROIC, Net debt / EBITDA, EV/EBITDA.

Versus the vertical median

Security & Commodity Brokers, Dealers, Exchanges & Services (SIC 6200) · same industry (4-digit SIC) · compared with 15 companies

The size band was not applied: too few companies would have remained; the vertical includes much smaller or larger companies.

Multiples and returns vs the median

P/E
25.1x
vertical median 23.7x
above median (+5.8%)
EV/EBITDA
—
vertical median 17.5x
P/S
2.9x
vertical median 6.7x
below median (−56.2%)
P/B
0.8x
vertical median 3.7x
below median (−79.4%)
ROE
16.1%
vertical median 14.1%
above median (+14.5%)
Net margin
63.3%
vertical median 3.2%
above median (+1,888.1%)
EBIT margin
65.7%
vertical median -14.4%
above median
Revenue YoY
6.4%
vertical median 26.9%
below median (−76.3%)
Net debt/EBITDA
—
vertical median 2.9x
Dividend yield
3.7%
vertical median 0.9%
above median (+330.0%)

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
ICEIntercontinental Exchange, Inc.97.2 bn23.714.2%29.6%+7.5%+11% / +53%
NDAQNasdaq, Inc.59.3 bn29.217.4%22.8%+11.6%+17% / +91%
CBOECboe Global Markets, Inc.36.8 bn25.127.4%28.0%+15.1%+37% / +94%
LPLALPL Financial Holdings Inc.23.4 bn17.325.7%6.8%+37.2%−15% / +35%
SNEXStoneX Group Inc.6.5 bn12.321.9%0.3%+32.5%+33% / +196%
MRXMarex Group Ltd4.7 bn16.828.7%14.5%+26.9%+87% / unavailable
TOPTop Financial Group Limited438.2 m—-1.0%-23.3%+41.9%+113% / −46%
EBONEbang International Holdings Inc.182.3 m—-5.6%-215.6%+11.4%−52% / −75%
GSIWGarden Stage Limited162.5 m7.5-89.5%-190.1%+33.2%−65% / unavailable
WTFWaton Financial Limited94.5 m—-87.9%-136.7%+48.8%−41% / unavailable
STEXStreamex Corp.38.0 m—-705.4%—+122.2%−93% / −87%
SOSSOS Limited20.9 m—-22.7%-63.1%−33.3%−85% / −100%
CMECme Group Inc.—25.116.1%63.3%+6.4%+15% / +44%
PLUTPlutus Financial Group Limited——-55.3%-377.3%+6.9%−64% / unavailable
BGCBGC Group, Inc.—25.519.5%6.0%+30.0%+20% / +61%
TWTradeweb Markets Inc.029.914.1%39.8%+18.9%+17% / +32%

1- and 3-year price returns: for CME from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (USD)

Estimated priceBearBaseBull
1 years
1,029.26
Total return 251% · Per year 251%
1,815.79
Total return 513% · Per year 513%
2,729.80
Total return 815% · Per year 815%
3 years
1,093.69
Total return 307% · Per year 60%
2,161.83
Total return 675% · Per year 98%
3,554.72
Total return 1,147% · Per year 132%
5 years
1,162.16
Total return 366% · Per year 36%
2,573.83
Total return 868% · Per year 57%
4,628.92
Total return 1,580% · Per year 76%
What moves the 3-year price the most
  • Exit P/E± 540.46
  • Net margin± 378.32
  • Annual revenue growth± 297.40
  • Annual dilution± 31.79

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

In brief

CME Group is the world's leading derivatives marketplace, headquartered in Chicago, offering futures, options, cash and OTC products and operating a central counterparty clearing house. Total revenues reached 1737.3 million USD in the third quarter of 2026, up 13% year on year 23. Revenue is dominated by clearing and transaction fees, which depend on contract volume 12.

SWOT

Strengths

  • Leading position in futures and options, with deep liquidity and repeated volume records.
  • In-house clearing house provides counterparty guarantee and margin efficiency for clients.
  • Diversification into market data and cash markets brings recurring revenue and global reach.

Weaknesses

  • Revenue depends heavily on trading volume, which can fall in quieter periods.
  • A single clearing member accounts for a significant share of clearing and transaction fee revenue.
  • Compliance costs and governance structure are under pressure from large clients.

Opportunities

  • SEC clearing requirements for Treasury and repo could open new revenue through CMESC.
  • Expansion in the Middle East, Asia, Europe and energy transition products could add volume.
  • The Google Cloud partnership and retail prediction products could create new distribution channels.

Threats

  • Pressure from large clearing firms to move clearing toward a non-profit structure could reduce control.
  • Larger or lighter-regulated competitors could offer lower prices and more attractive products.

Risks

  • Dependence on trading volumehigh

    Revenue fluctuates with volume, and a quiet period in markets could significantly reduce fees.

  • Concentration on one clearing membermedium

    A single clearing member represents a material share of clearing fees; its withdrawal could affect revenue.

  • Regulatory pressuremedium

    Regulatory changes or legal interpretations on event contracts could limit the products offered.

  • Technology and cyber riskmedium

    Platform failures, cyberattacks or the cloud migration could disrupt trading.

  • Fee pressurelow

    Competition and tariff structure could reduce margins if fees are changed.

Investment thesis

What would need to be true (bull case)

  • Record volumes and rising revenue in 2026 show that demand for risk management remains strong.
  • The clearing house position and deep liquidity create competitive barriers that are hard to replicate.
  • Data services and new products can diversify revenue and reduce reliance on trading volume.

What would break the thesis

  • Revenue depends on volatility; a calmer market could significantly reduce volumes and fees.
  • Competitive pressure and a falling average rate per contract could erode margins over time.
  • Regulatory changes, including a possible transaction tax, could slow growth.

What to watch

  • Launch of the CMESC securities clearing service2026
  • Trend in the average rate per contract and volumeQ4 2026

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

The business

CME Group lets clients trade futures, options, cash and OTC products, optimize portfolios and analyze data, through the CME, CBOT, NYMEX and COMEX exchanges 1. In fiscal 2025 average daily volume of futures and options was a record 28.1 million contracts 1. The company also operates the CME clearing house, which becomes counterparty to every trade and limits counterparty credit risk 1.

The company's strategy has three directions: growing futures and options globally, diversifying through cash markets and data services, and delivering operational efficiencies for clients, including through its Google Cloud partnership 1.

Segments

Derivatives exchanges and clearing

The core segment includes futures and options on interest rates, equity indices, foreign exchange, energy, metals, agricultural products and cryptocurrencies, traded mainly on CME Globex 1. In fiscal 2025, 85% of contract volume came from trades by members 1.

Cash markets and data services

Cash markets include BrokerTec for fixed income and repo and EBS for spot FX and spot precious metals, which generated 283.7 million USD of clearing and transaction fees in fiscal 2025 1. Data services provide real-time and historical market data, benchmarks and alternative data, with a significant share of market data revenue from outside the U.S. 1.

Securities clearing

In December 2025 CMESC received SEC approval to become a securities clearing agency, aiming to help participants meet clearing requirements for U.S. Treasury and repo transactions, with launch expected later in 2026 1.

Market context

The derivatives market was active in 2026, with high volatility driven by inflationary pressure and the Middle East conflict, which lifted volumes in interest rates, equities and metals 2. Average daily volume in the third quarter of 2026 reached 29.4 million contracts, a third-quarter record 3.

Competition comes from other exchanges, OTC markets, crypto and prediction platforms, and technology and data providers 1. Regulatory change and pressure from large clearing firms on clearing house ownership remain points to watch 1.

Trends

  • Macroeconomic volatilitytailwind

    Economic and geopolitical uncertainty has increased hedging and speculative volumes, and in 2026 Federal Reserve rate increases drove heavy Treasury trading 2. If volatility declines, volumes could return to more moderate levels.

  • Pressure on feesheadwind

    The average rate per contract declined in 2026, and competitors could offer more competitive pricing, which could reduce margins 12.

  • Regulation and clearing requirementsmixed

    SEC clearing requirements for Treasury and repo transactions could create new opportunities but also compliance costs and pressure on the business model 1.

Competitive position

CME Group acknowledges competition from futures, securities and options exchanges, OTC markets, clearing organizations, crypto and prediction platforms, and technology providers 1. Larger competitors may respond faster to pricing pressure and exploit regulatory differences 1.

The company argues that its brand, liquidity depth, margin efficiency and product diversity give it an edge, but warns that competitive pressure will keep intensifying 1. Losing major customers or cutting fees could affect profitability 1.

  • Intercontinental ExchangeICE

    Exchange and data operator, a benchmark competitor in derivatives and market data, grouped among other exchanges in the sources.

  • Cboe Global MarketsCBOE

    Operator of options and volatility exchanges that competes on options products and trading volumes.

  • NasdaqNDAQ

    Exchange and market data provider, relevant in index markets and data services.

  • Crypto and prediction platforms

    New platforms competing for trading volume, especially in crypto and event contracts, explicitly named in the source.

News & filings

In the press

The latest news item in our archive is from 22 Sept 2026; the newest SEC filing is from 23 Oct 2026. The press archive comes from the RSS feeds we follow and does not necessarily cover the latest event — the filings alongside do.

SEC filings

Sources

  1. [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / CME Group Inc. · 26 Feb 2026
  2. [2] Form 10-Q, quarter ended 2026-09-30 · SEC / CME Group Inc. · 23 Oct 2026
  3. [3] Form 8-K, results release (exhibit 99.1) · SEC / CME Group Inc. · 21 Oct 2026

Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.